The U.S. durable medical equipment market size was valued at USD 59.7 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.7% from 2023 to 2030. The COVID-19 pandemic has affected the supply chain of durable medical equipment (DME). The market is majorly driven by the rising product demand due to the growing geriatric population that is susceptible to various chronic diseases, such as cancer, diabetes, Cardiovascular Diseases (CVDs), neurological disorders, and mobility disorders.
The COVID-19 pandemic has initially disrupted the market due to the lack of accessibility of the products to the customers. The pandemic has affected the operations and financial condition of various market players. The DME suppliers have encountered interruptions in the supply chain, such as significant delays and order cancellations, as a result of public health and economic emergencies related to the COVID-19 pandemic.
The durable medical equipment suppliers are facing numerous challenges in serving patients requiring respiratory support and other DME-related services. Cancer is a leading cause of death globally accounting for 10 million deaths in 2020. As per the National Cancer Institute Report 2018, approximately 1.7 million people in the U.S. were diagnosed with cancer.
It is predicted that there will be a 70.0% rise in the new cases of cancer over the next couple of years (about 1.1 million people). The rising prevalence of neurological diseases, such as Alzheimer’s, Parkinson’s, and Epilepsy, is also expected to fuel the product demand. As per the statistics of the Centers for Disease Control and Prevention, in 2020, 5.8 million Americans were living with Alzheimer’s disease. The rising prevalence of diseases is expected to result in an increase in demand for DME over the forecast period. In addition, an increase in healthcare spending across the country is expected to boost market growth.
The demographic shifts underlie the projected growth in the U.S. healthcare expenditure from USD 3.5 trillion in 2017 to USD 6.2 trillion in 2028 and account for 20% of the GDP. The anticipated growth in the annual spending for Medicare (7.9%) is projected to contribute significantly to the increase in the national health expenditure over the forecast period. Since its inception, Medicare has accounted for an increasing proportion of the total healthcare expenditure. Medicare has covered 18.4% of U.S. Americans in 2020 and in 2021, more than 26 million people enrolled in Medicare Advantage Plan.
The monitoring and therapeutic devices segment held the largest revenue share of over 89.3% in 2022 due to the increasing prevalence of chronic diseases requiring long-term care. In addition, increasing patient preference for at-home medical treatment or remote medical services over an in-patient setting is contributing to the segment growth. In monitoring and therapeutic devices, neuromonitoring techniques are expected to witness growth over the forecast period as they are becoming a part of standard medical practices and are routinely used during many surgical procedures.
The personal mobility devices segment is anticipated to register the fastest growth rate of 6.0% during the forecast period. The growing geriatric population and rising chronic illnesses are likely to create more need and demand for mobility products over the forecast period as these factors generally reduce the ability to move and perform physical tasks to maintain independent functioning. Moreover, aged people are more prone to falls, which can cause fatal or non-fatal injuries.
The key companies are continuously focusing on initiatives such as mergers & acquisitions, regional expansion, and novel product development. For instance, in December 2020, Arjo completed the acquisition of AirPal, which is likely to strengthen Arjo’s Patient Handling portfolio. The market players are introducing innovative technologies and products to expand their product portfolio to capture a large share in the market. The market consists of big players as well as local distributors and suppliers. The key players are focusing on providing cost-efficient products, which can be used remotely. Some prominent players in the U.S. durable medical equipment include:
Invacare Corp.
Sunrise Medical
Arjo
Medline Industries, Inc.
GF Healthcare Products, Inc.
Carex Health Brands, Inc.
Cardinal Health
Drive DeVilbiss Healthcare
NOVA Medical Products
Kaye Products, Inc.
Report Attribute |
Details |
Market size value in 2023 |
USD 63.2 billion |
Revenue forecast in 2030 |
USD 92.9 billion |
Growth rate |
CAGR of 5.7% from 2023 to 2030 |
Base year for estimation |
2022 |
Historical data |
2019 - 2021 |
Forecast period |
2023 - 2030 |
Quantitative units |
Revenue in USD million/billion and CAGR from 2023 to 2030 |
Report coverage |
Revenue forecast, competitive landscape, growth factors, and trends |
Segments covered |
Product, end-use |
Country scope |
U.S. |
Key companies profiled |
Invacare Corp.; Sunrise Medical; Arjo; Medline Industries, Inc.; GF Healthcare Products, Inc.; Carex Health Brands, Inc.; Cardinal Health; Drive DeVilbiss Healthcare; NOVA Medical Products; Kaye Products, Inc. |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country and segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. durable medical equipment market report based on product and end-use:
Product Outlook (Revenue, USD Million, 2018 - 2030)
Personal Mobility Devices
Wheelchairs
Electric Wheelchairs
Manual Wheelchairs
Scooters
Walker and Rollators
Cranes and Crutches
Door Openers
Other Devices
Bathroom Safety Devices and Medical Furniture
Commodes and Toilets
Mattress & Bedding Devices
Monitoring and Therapeutic Devices
Blood Glucose Monitors
Continuous Passive Motion (CPM)
Infusion Pumps
Nebulizers
Oxygen Equipment
Continuous Positive Airway Pressure (CPAP)
Suction Pumps
Traction Equipment
Others Equipment
Insulin Pumps
Ostomy Bags & Accessories
Wound Care Products
Cardiology Devices
Vital Signs Monitor
Respiratory Supplies
Urinary Supplies
Diabetic Supplies
Incontinence Products
Orthopedic Braces & Support
Muscle Stimulators
Others
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Diagnostic Centers
Home Healthcare
Others
b. The U.S. durable medical equipment market size was established at USD 59.7 billion in 2021 and is expected to reach USD 63.2 billion in 2023.
b. The U.S. durable medical equipment market is expected to grow at a compound annual growth rate of 5.7% from 2023 to 2030 to reach USD 92.9 billion by 2030.
b. The monitoring and therapeutic devices segment dominated the U.S. durable medical equipment market with a share of 89.3% in 2022. This is attributable to their ease of use, convenience, and patient preference for the equipment.
b. Some key players operating in the U.S. DME market include Invacare Corporation; Sunrise Medical; ArjoHuntleigh; Hill-Rom; Stryker; Medline Industries, Inc.; Medical Device Depot, Inc.; GF Health Products Inc.; Carex Health Brands; Baxter International, Inc.; Becton, Dickinson and Company; and Joerns Healthcare LLC.
b. Key factors that are driving the U.S. durable medical equipment market growth include an increase in the prevalence of chronic disease, rapid technological advancements, and a rising aging population.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
We value your investment and offer free customization with every report to fulfil your exact research needs.